Received Mar 13, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEPAB | HEP A + HEP B (TWINRIX) | GLAXOSMITHKLINE BIOLOGICALS | 2 | UNK | — |
a female patient received a 1st Twinrix dose on 04-Nov-2024; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a 45-year-old female patient who received HAB (Twinrix) for prophylaxis. Previously administered products included Twinrix (a female patient received a 1st Twinrix dose on 04-Nov-2024, batch number 2KR55, expiry date 03 January 2025). On an unknown date, the patient did not receive the 2nd dose of Twinrix. On an unknown date, an unknown time after receiving Twinrix, the patient experienced incomplete course of vaccination (Verbatim: a female patient received a 1st Twinrix dose on 04-Nov-2024). The outcome of the incomplete course of vaccination was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date : 06-MAR-2025 On 06th March 2025 pharmacist mentioned that a female patient received a 1st Twinrix dose on 04th November 2024, and now, the patient was late for the 2nd dose. Till the time of reporting, the patient did not receive 2nd dose of Twinrix, which led to incomplete course of vaccination.